<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/101</identifier>
				<datestamp>2021-08-31T02:18:08Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Influence of vaccination with a combined chemically altered/inactivated BHV-1/BVD vaccine or a modified- live BHV-1/BVD vaccine on reproductive performance in beef cows and heifers</dc:title>
	<dc:creator xml:lang="en">Perry, George A.</dc:creator>
	<dc:creator xml:lang="en">Geary, Thomas W.</dc:creator>
	<dc:creator xml:lang="en">Walker, Julie A.</dc:creator>
	<dc:creator xml:lang="en">Rich, Jerica J. J.</dc:creator>
	<dc:creator xml:lang="en">Northrop, Emmalee J.</dc:creator>
	<dc:creator xml:lang="en">Perkins, Stephanie D.</dc:creator>
	<dc:creator xml:lang="en">Mogck, Christina L.</dc:creator>
	<dc:creator xml:lang="en">Van Emon, Megan L.</dc:creator>
	<dc:creator xml:lang="en">Zezeski, Abby L.</dc:creator>
	<dc:creator xml:lang="en">Daly, Russell F.</dc:creator>
	<dc:subject xml:lang="en">modified-live</dc:subject>
	<dc:subject xml:lang="en">inactivated</dc:subject>
	<dc:subject xml:lang="en">vaccine</dc:subject>
	<dc:subject xml:lang="en">reproduction</dc:subject>
	<dc:subject xml:lang="en">conception rates</dc:subject>
	<dc:description xml:lang="en">A field trial was conducted on 10 herds of previously- vaccinated cows and heifers (n=1,567) to evaluate the reproductive effects of prebreeding vaccination with either a modified-live virus (MLV) or a chemically altered/inactivated (CA/IV] BHV-1/BVDV vaccine. Animals received a single (cows) or 2 injections (heifers) of either vaccine, with the final injection between 27 and 89 days before breeding, which consisted of timed AI following a 7-d CO-Synch + CIDR synchronization. Conception rates to AI were greater in the CA/IV vaccine group compared to the MLV vaccine group (P=0.05; 60% vs 52%). Interval from vaccination with either vaccine until AI also influenced conception rates (P=0.02), with animals vaccinated 27 to 29 (52%) days or 30 to 37 (52%) days prebreeding exhibiting decreased conception rates compared to animals vaccinated 46 to 89 days prebreeding (P&amp;lt;0.03; 64%). There was no treatment by interval interaction (P=0.79), effect of treatment (P=0.18), or treatment by interval interaction (P=0.17) on breeding season pregnancy rates. In summary, vaccination of previously vaccinated beef cows and heifers with a MLV vaccine pre-breeding (27 to 89 d) was associated with decreased AI conception rates compared to a CA/IV vaccine.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2018-02-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/101</dc:identifier>
	<dc:identifier>10.21423/bovine-vol52no1p53-58</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 52, No. 1 (2018 Spring); 53-58</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/101/92</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2018 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
